Vimarsana
Biggest News Aggregation in the World

Page 25 - Chest Physicians News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chest Physicians. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chest Physicians Today - Breaking & Trending Today

Mediastinal cryobiopsy: safe and effective but in whom and when? - Vimarsana News

Mediastinal cryobiopsy: safe and effective but in whom and when?

Linear endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (EBUS-TBNA) for real-time mediastinal tissue sampling was a transformative development in the evolving landscape of cancer diagnosis. Techniques for fine needle aspiration of mediastinal masses had been described as early as 1949 and then by Wang and colleagues1 in 1978; however, major technological advances were necessary for EBUS-TBNA to become a mainstream tool in the modern era. With non-inferior sensitivity, and favourable risk profile and cost-effectiveness, compared with gold-standard surgical mediastinoscopy...

Iron Deficiency May Protect Against Bacterial Pneumonia - Vimarsana News

Iron Deficiency May Protect Against Bacterial Pneumonia

Iron deficiency is the most common nutritional deficiency, but iron is also required for the survival and growth of pathogens, experts say.

Statin Use May Reduce Risk for Lung Cancer in Patients With IPF - Vimarsana News

Statin Use May Reduce Risk for Lung Cancer in Patients With IPF

Patients with IPF who take statins for over 30 days following diagnosis have decreased risk for developing lung cancer.

Source: empr.com
Extracorporeal Membrane Oxygenation Increases Risk in Certain Comorbidities - Vimarsana News

Extracorporeal Membrane Oxygenation Increases Risk in Certain Comorbidities

Patients with comorbid OSA or hepatic failure are more likely to have poor outcomes following extracorporeal membrane oxygenation.

Source: empr.com
Dupilumab Reduces Oral Corticosteroid Use in OCS-Dependent Severe Asthma - Vimarsana News

Dupilumab Reduces Oral Corticosteroid Use in OCS-Dependent Severe Asthma

Dupilumab reduced the oral corticosteroid dose needed by individuals with OCS-dependent severe asthma while maintaining and improving asthma outcomes.

Source: empr.com